
CONCUSSION PREVENTION
A new way of imaging the brain will help engineer better helmets to prevent traumatic brain injuries.
Research that improves the quality of human life.
The healthcare industry accounts for a full 18 percent of the nation’s gross domestic product (GDP), and Stevens produces key research that develops tools to improve medical outcomes; makes patients more comfortable; and supports the planning and operation of medical facilities.
Coordinated by the interdisciplinary Center for Healthcare Innovation (CHI), Stevens faculty and student researchers make significant scientific contributions to the pharmaceutical, biotechnology and medical device industries, to clinical research organizations and medical centers, and to healthcare policy, delivery and management. Interdisciplinary teams capitalize on innovative developments in biology, chemistry, engineering, computer science, management, pharmaceutical manufacturing and business and leverage new nano- and micro-scale technologies to help translate laboratory innovation to patient care and well-being. We also perform research in a range of key related domains such as tissue engineering, computational drug discovery, biomaterial and biosensor development, and healthcare analytics.
Current Stevens projects include a search for cancer drugs targeting the RAS and ERK signaling pathways; searches for emerging therapies for traumatic lung injury and Parkinson's disease; methods that assist the analysis of ICU data to improve stroke-patient care; and work to improve disease models and research protocols for multiple myeloma, breast and prostate cancers and osteoporosis.
A new way of imaging the brain will help engineer better helmets to prevent traumatic brain injuries.
Stevens researchers partner with a major medical center to develop a new quick-test for viral and bacterial infections.
NIH-supported Stevens project in "tumor engineering" may open a pathway to better therapries for a destructive blood cancer.
A novel Stevens-developed technology could help image skin and other body tissues for diagnosis more effectively.
New research at Stevens promises to help improve therapries for Parkinson's Disease, OCD and other disorders.
Stevens researchers harness computational power to search for the next great medicines.
Chemistry Professor Athula B. Attygalle: R&D Council of NJ 2017 Edison Patent Award Winner
3D Bacterial Models from Antibacterial Drug Research
Creating Life-Like Skin Grafts for Burn Victims
National Institutes of Health (NIH)
National Science Foundation (NSF)
Merck
Columbia University